Pharmalittle: Moderna sees $18 billion in Covid vaccine sales despite production woes; U.K. clears Merck Covid pill

Moderna cut its full-year sales forecast for its Covid-19 vaccine to between $15 billion and $18 billion from $20 billion estimated previously, as the vaccine maker struggles with the production of its two-dose inoculation, Reuters notes. The company is now expecting deliveries of between 700 million and 800 million doses this year, down from its prior expectations of between 800 million and 1 billion doses. The Covid-19 vaccine is now expected to generate between $15 billion and $18 billion in sales this year. That estimate was lowered because fewer doses are now set to be delivered this year.